Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Drug Chem Toxicol ; 39(3): 279-83, 2016.
Article in English | MEDLINE | ID: mdl-26446802

ABSTRACT

Although it is generally believed that the developing fetus is principally exposed to inorganic arsenic and the methylated metabolites from the maternal metabolism of arsenic, little is known about whether the developing embryo can autonomously metabolize arsenic. This study investigates inorganic arsenic methylation by murine embryonic organ cultures of the heart, lung, and liver. mRNA for AS3mt, the gene responsible for methylation of arsenic, was detected in all embryonic tissue types studied. In addition, methylated arsenic metabolites were generated by all three tissue types. The fetal liver explants yielded the most methylated arsenic metabolites (∼7% of total arsenic/48 h incubation) while the heart, and lung preparations produced slightly greater than 2% methylated metabolites. With all tissues the methylation proceeded mostly to the dimethylated arsenic species. This has profound implications for understanding arsenic-induced fetal toxicity, particularly if the methylated metabolites are produced autonomously by embryonic tissues.


Subject(s)
Arsenites/metabolism , Heart , Liver/metabolism , Lung/metabolism , Myocardium/metabolism , Sodium Compounds/metabolism , Animals , Arsenites/toxicity , Biotransformation , Female , Gene Expression/drug effects , Heart/drug effects , Heart/embryology , Liver/drug effects , Liver/embryology , Lung/drug effects , Lung/embryology , Methylation , Methyltransferases/genetics , Methyltransferases/metabolism , Mice , Organ Culture Techniques , Sodium Compounds/toxicity
SELECTION OF CITATIONS
SEARCH DETAIL
...